Work

A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens

Year: 2017

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Therapeutics

DOI: 10.1016/j.clinthera.2017.07.007

Authors: David B. Huang, Thomas M. File, Antoni Torres, Andrew F. Shorr, Mark H. Wilcox, Paul Hadvary, Matthew Dryden, G. Ralph Corey

Institutions: Motif BioSciences (United States), Summa Health System, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Universitat de Barcelona, MedStar Washington Hospital Center, University of Leeds, Leeds Teaching Hospitals NHS Trust, Hampshire Hospitals NHS Foundation Trust, Duke Medical Center

Language: English

Topic: Antibiotics Pharmacokinetics and Efficacy

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2741632646

FWCI: 2.864

Cites: 23

Cited by: 21

Related to: 10